Otofarma SpA (MIL:OTO) Short-Term Debt: €1.57 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.70
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Short-Term Debt?

Otofarma SpA MIL:OTO -2.17% 16 Short-Term Debt is €1.57 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Short-Term Debt for the quarter that ended in Dec. 2024 was €1.57 Mil.

Otofarma SpA's quarterly Short-Term Debt increased from . 20 (€0.00 Mil) to Dec. 2023 (€1.08 Mil) and increased from Dec. 2023 (€1.08 Mil) to Dec. 2024 (€1.57 Mil).

Otofarma SpA's annual Short-Term Debt increased from . 20 (€0.00 Mil) to Dec. 2023 (€1.08 Mil) and increased from Dec. 2023 (€1.08 Mil) to Dec. 2024 (€1.57 Mil).

Otofarma SpA Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Otofarma SpA Short-Term Debt Related Terms

Otofarma SpA Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Short-Term Debt Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Short-Term Debt
1.08 1.57

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Short-Term Debt 1.08 1.57
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €1.57 Mil mean?
Otofarma SpA (MIL:OTO) has a Short-Term Debt of €1.57 Mil as of Dec. 2024.
Is Otofarma SpA's Short-Term Debt too high?
Otofarma SpA's current Short-Term Debt is €1.57 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Short-Term Debt compare to ABT and SYK?
Otofarma SpA's Short-Term Debt of €1.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Otofarma SpA's current Short-Term Debt is €1.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Short-Term Debt of €1.57 Mil. The current Short-Term Debt is €1.57 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Short-Term Debt is €1.57 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.70
Price